Historical Stock Price
BCRX historical stock prices picture
BioCryst Pharmaceuticals (BCRX) has the following price history information. Looking back at BCRX historical stock prices for the last five trading days, on April 12, 2024, BCRX opened at $5.10, traded as high as $5.16 and as low as $4.70, and closed at $4.77. Trading volume was a total of 4.53M shares. On April 15, 2024, BCRX opened at $4.78, traded as high as $4.79 and as low as $4.59, and closed at $4.67. Trading volume was a total of 2.50M shares. On April 16, 2024, BCRX opened at $4.61, traded as high as $4.72 and as low as $4.54, and closed at $4.61. Trading volume was a total of 1.98M shares. On April 17, 2024, BCRX opened at $4.65, traded as high as $4.79 and as low as $4.57, and closed at $4.58. Trading volume was a total of 4.06M shares. On April 18, 2024, BCRX opened at $4.60, traded as high as $4.71 and as low as $4.49, and closed at $4.50. Trading volume was a total of 2.96M shares.

BCRX Historical Stock Prices By Date:

BCRX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into BioCryst Pharmaceuticals shares, starting with a $10,000 purchase of BCRX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 04/18/2024
Start price/share: $9.20
End price/share: $4.50
Dividends collected/share: $0.00
Total return: -51.09%
Average Annual Total Return: -6.90%
Starting investment: $10,000.00
Ending investment: $4,893.08
Years: 10.00
Date Open High Low Close Volume
04/12/2024 $5.10 $5.16 $4.70 $4.77 4.53M
04/15/2024 $4.78 $4.79 $4.59 $4.67 2.50M
04/16/2024 $4.61 $4.72 $4.54 $4.61 1.98M
04/17/2024 $4.65 $4.79 $4.57 $4.58 4.06M
04/18/2024 $4.60 $4.71 $4.49 $4.50 2.96M
BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO™ (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza.
Date Close
04/12/2024$4.77
04/15/2024$4.67
04/16/2024$4.61
04/17/2024$4.58
04/18/2024$4.50
BCRX is categorized under the Healthcare sector; below are some other companies in the same sector:

BDMS Historical Stock Prices
BDSI Historical Stock Prices
BDX Historical Stock Prices
BDXA Historical Stock Prices
BEAT Historical Stock Prices
BGMD Historical Stock Prices
BIIB Historical Stock Prices
BIND Historical Stock Prices
BIO Historical Stock Prices
BIOC Historical Stock Prices

Also explore: BCRX shares outstanding history

Email EnvelopeFree BCRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


BCRX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.